Skip to main content
Top
Published in: Medical Microbiology and Immunology 3-4/2019

01-08-2019 | Editorial

‘Checks and balances’ in cytomegalovirus-host cohabitation

Author: Matthias J. Reddehase

Published in: Medical Microbiology and Immunology | Issue 3-4/2019

Login to get access

Excerpt

Species-specific cytomegaloviruses (CMVs) and their corresponding hosts have co-speciated during eons of co-evolution adapting to each other by establishing ‘checks and balances’. Accordingly, CMVs of different host species have acquired different sets of private genes dedicated to moderate intrinsic, innate, and adaptive defense mechanisms of their respective host, and those, in turn, have found counterstrategies to keep their lodger in check. The popular term ‘immune evasion’ of CMVs is clearly an unfortunate misnomer, as immune surveillance of CMV infections prevents viral pathogenesis so that CMV disease is restricted to the immunocompromised or immunologically immature host. The immune response resolves acute infection with no overt symptoms of CMV disease, neither symptoms of viral pathogenesis nor of immunopathogenesis. Lifelong immune surveillance keeps the virus in a non-replicative state referred to as latency. Latency is defined as absence of infectious virus but durable retention of reactivation-competent viral genomes. Productive recurrent infection can be re-initiated by not yet fully defined signals resulting in virus spread and histopathology under conditions of compromised immune control. …
Literature
Metadata
Title
‘Checks and balances’ in cytomegalovirus-host cohabitation
Author
Matthias J. Reddehase
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Medical Microbiology and Immunology / Issue 3-4/2019
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-019-00618-5

Other articles of this Issue 3-4/2019

Medical Microbiology and Immunology 3-4/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.